﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Mon, 20 Apr 2026 11:29:10 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/September-2023/rss/1476</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/September-2023/rss/1476" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Updates from FDA]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/updates-from-fda-15</link><description><![CDATA[ New drugs 

 QUIZARTINIB 

 (Vanflyta—Daiichi Sankyo, Inc.) 

  Drug class:  Vanflyta is a kinase inhibitor. 

  Indication:  Vanflyta is indicated in combination with standard cytarabine ...]]></description><pubDate>Thu, 07 Sep 2023 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/updates-from-fda-15</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-1608]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Regaining those pearly whites]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/regaining-those-pearly-whites</link><description><![CDATA[  Mary Warner  

   

 Patient demand for tooth whitening has been on the increase for several years, bolstered by the availability of a wide variety of nonprescription whitening toothpastes and ...]]></description><pubDate>Thu, 07 Sep 2023 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/regaining-those-pearly-whites</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-1609]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Testosterone-replacement therapy unlikely to increase risk of cardiac events]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/testosterone-replacement-therapy-unlikely-to-increase-risk-of-cardiac-events</link><description><![CDATA[   

  Clarissa Chan, PharmD  

 Results of a recent trial published in the July 13, 2023, issue of  NEJM  found men 45 to 80 years old who took testosterone-replacement therapy were unlikely to ...]]></description><pubDate>Thu, 07 Sep 2023 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/testosterone-replacement-therapy-unlikely-to-increase-risk-of-cardiac-events</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-1612]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New treatment option for pediatric T2D]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-treatment-option-for-pediatric-t2d</link><description><![CDATA[   

  Lauren Howell, PharmD  

 This past June, FDA approved the first new class of medicines to treat pediatric T2D since 2000. Previously limited to metformin, children 10 years or older with ...]]></description><pubDate>Thu, 07 Sep 2023 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-treatment-option-for-pediatric-t2d</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-1613]]></dc:identifier></item></channel></rss>